Mark Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies. Mr. Foster will provide strategic council to augment current fundraising, production, commercialization and distribution efforts at Xenocor.

He is currently the CEO of Trice Medical a venture-backed company that has a portfolio of products for minimally invasive diagnostic and therapeutic orthopedic procedures.  In his tenure at Trice, he has acquired and integrated two companies, raised over 60M of debt/equity, expanded the employee base from 12 to 100 and drove significant increase in asset value.

He has held senior management positions focused on business development to include fund-raising, licensing, M&A, commercialization and supply chain initiatives at two large, public companies, Smith and Nephew and Boston Scientific.

In addition to his role at Trudell, George is an active investor in and Director of several medical device and e-health / connected care companies including Sensory Technologies, Mozzaz Corporation, and Sky Medical Technology Inc. He was also a lead investor and a former Director of Vanrx Phamasystems, which was recently acquired by Cytiva Life Sciences.